Botulinum Toxin for the Management of Spasticity

Dear Colleagues,

Spasticity is a serious consequence of several neurological diseases. This complication often contributes to increased disability and limits individual independence. Spasticity often influences the ability to perform daily activities and may even restrict possibilities to receive help from caretakers. There is an unmet need for knowledge among medical personnel about possibilities to change and prevent debilitating spasticity. The need for the management and modulation of spasticity should be continuously included in clinical evaluations both in general and specialized clinical practice. Therapy with Botulinum toxins is one of the advances that should be considered to improve function in spastic limb. Development and knowledge about indications and advisable and rational treatment has changed over time.

This issue aims to help with the optimal evaluation and management of spasticity using Botulinum toxins that may relieve individual disability and enhance independence. There is a need for updated knowledge of timing as well as possibilities to change functional status using Botulinum toxins. Information and reports of new possibilities to apply this therapy in spasticity are welcome. The latest data on spasticity and Botulinum toxin therapy, approaches, dosage and timeline, recommended routines, use of medical equipment, and follow-up studies are included to this issue. Implications of and approaches to treatment of different neurological disorders using Botulinum toxins need to be updated. Data from recent studies and/or observations are welcome in this issue.

Prof. Dr. Tiina E. Rekand
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a double-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Toxins is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• spasticity
• Botulinum toxins
• neurological disorders
• guidelines
• medical equipment